News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024